|
RMS Multivariable Modeling Strategies
|
|
76
|
32299
|
October 28, 2025
|
|
RMS General Regression
|
|
121
|
35093
|
May 22, 2025
|
|
Using 2 different measures of the same entity for risk prediction
|
|
3
|
957
|
November 12, 2024
|
|
Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
|
33
|
13182
|
June 16, 2023
|
|
Interactions and random error
|
|
24
|
12238
|
October 20, 2022
|
|
Compare ORs between strata with log(OR) difference or use interactions?
|
|
0
|
1508
|
July 21, 2022
|
|
Relative excess risk due to interaction (RERI) from a multiplicative model
|
|
3
|
4920
|
April 20, 2022
|
|
Making sense of significant interaction with null main effect in RCT
|
|
3
|
11690
|
December 24, 2020
|
|
Basic question regarding model specification for interaction testing using a Cox PH Model
|
|
6
|
3229
|
September 23, 2020
|
|
Subgroup Interaction
|
|
2
|
4269
|
April 8, 2020
|
|
RCT generalizability and interactions with treatment
|
|
8
|
5392
|
March 10, 2020
|
|
Bayesian Modeling of Patient-Specific Efficacy Estimates and HTE
|
|
2
|
4238
|
July 2, 2019
|
|
How to display and tabulate interaction effects in a longitudinal model
|
|
1
|
5415
|
December 14, 2018
|